CVS Health Corp (CVS) Stake Raised by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lifted its position in CVS Health Corp (NYSE:CVS) by 130.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,269 shares of the pharmacy operator’s stock after buying an additional 13,742 shares during the quarter. Assenagon Asset Management S.A.’s holdings in CVS Health were worth $1,974,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Jackson Grant Investment Advisers Inc. lifted its holdings in shares of CVS Health by 0.6% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator’s stock worth $232,000 after buying an additional 18 shares in the last quarter. Elefante Mark B lifted its holdings in shares of CVS Health by 0.7% in the second quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock worth $515,000 after buying an additional 45 shares in the last quarter. Traynor Capital Management Inc. lifted its holdings in shares of CVS Health by 1.3% in the second quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock worth $290,000 after buying an additional 48 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of CVS Health by 0.8% in the second quarter. Sequoia Financial Advisors LLC now owns 6,406 shares of the pharmacy operator’s stock worth $515,000 after buying an additional 53 shares in the last quarter. Finally, Brookstone Capital Management lifted its holdings in shares of CVS Health by 1.8% in the second quarter. Brookstone Capital Management now owns 3,153 shares of the pharmacy operator’s stock worth $254,000 after buying an additional 55 shares in the last quarter. 81.63% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Corp (NYSE CVS) opened at $71.67 on Tuesday. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. CVS Health Corp has a fifty-two week low of $66.45 and a fifty-two week high of $84.72. The stock has a market cap of $74,029.46, a P/E ratio of 12.80, a PEG ratio of 1.37 and a beta of 0.89.

CVS Health (NYSE:CVS) last issued its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. During the same quarter last year, the business earned $1.64 earnings per share. The business’s revenue was up 3.5% on a year-over-year basis. research analysts forecast that CVS Health Corp will post 5.9 EPS for the current fiscal year.

In other news, EVP Thomas M. Moriarty sold 20,547 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the transaction, the executive vice president now owns 43,178 shares in the company, valued at $3,504,758.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.61% of the stock is currently owned by company insiders.

CVS has been the topic of a number of recent analyst reports. Loop Capital initiated coverage on shares of CVS Health in a research note on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price on the stock. BidaskClub downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Needham & Company LLC reaffirmed a “hold” rating on shares of CVS Health in a research note on Sunday, September 10th. Jefferies Group raised their target price on shares of CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research note on Friday, September 15th. Finally, Royal Bank of Canada initiated coverage on shares of CVS Health in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price on the stock. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company’s stock. CVS Health has an average rating of “Buy” and an average target price of $86.35.

COPYRIGHT VIOLATION WARNING: “CVS Health Corp (CVS) Stake Raised by Assenagon Asset Management S.A.” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://sportsperspectives.com/2017/12/19/cvs-health-corp-cvs-stake-raised-by-assenagon-asset-management-s-a.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply